218 related articles for article (PubMed ID: 32954630)
1. One-year conditional survival of dogs and cats with invasive mammary carcinomas: A concept inspired from human breast cancer.
Chocteau F; Mordelet V; Dagher E; Loussouarn D; Abadie J; Nguyen F
Vet Comp Oncol; 2021 Mar; 19(1):140-151. PubMed ID: 32954630
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study.
Dagher E; Abadie J; Loussouarn D; Fanuel D; Campone M; Nguyen F
BMC Vet Res; 2019 Jan; 15(1):25. PubMed ID: 30630524
[TBL] [Abstract][Full Text] [Related]
3. Feline Invasive Mammary Carcinomas: Prognostic Value of Histological Grading.
Dagher E; Abadie J; Loussouarn D; Campone M; Nguyen F
Vet Pathol; 2019 Sep; 56(5):660-670. PubMed ID: 31113336
[TBL] [Abstract][Full Text] [Related]
4. Immunological aspects of mammary tumors in dogs and cats: a survey including own studies and pertinent literature.
Rutten VP; Misdorp W; Gauthier A; Estrada M; Mialot JP; Parodi AL; Rutteman GR; Weyer K
Vet Immunol Immunopathol; 1990 Nov; 26(3):211-25. PubMed ID: 2264285
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of histologic grading for feline mammary carcinoma: a retrospective survival analysis.
Mills SW; Musil KM; Davies JL; Hendrick S; Duncan C; Jackson ML; Kidney B; Philibert H; Wobeser BK; Simko E
Vet Pathol; 2015 Mar; 52(2):238-49. PubMed ID: 25060990
[TBL] [Abstract][Full Text] [Related]
6. Grade is an independent prognostic factor for feline mammary carcinomas: a clinicopathological and survival analysis.
Seixas F; Palmeira C; Pires MA; Bento MJ; Lopes C
Vet J; 2011 Jan; 187(1):65-71. PubMed ID: 19955006
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats.
Murakami Y; Tateyama S; Rungsipipat A; Uchida K; Yamaguchi R
J Vet Med Sci; 2000 Jul; 62(7):743-50. PubMed ID: 10945293
[TBL] [Abstract][Full Text] [Related]
8. Prognostic studies of canine and feline mammary tumours: the need for standardized procedures.
Matos AJ; Baptista CS; Gärtner MF; Rutteman GR
Vet J; 2012 Jul; 193(1):24-31. PubMed ID: 22296767
[TBL] [Abstract][Full Text] [Related]
9. Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors.
Nguyen F; Peña L; Ibisch C; Loussouarn D; Gama A; Rieder N; Belousov A; Campone M; Abadie J
Breast Cancer Res Treat; 2018 Feb; 167(3):635-648. PubMed ID: 29086231
[TBL] [Abstract][Full Text] [Related]
10. Results of excision of thymoma in cats and dogs: 20 cases (1984-2005).
Zitz JC; Birchard SJ; Couto GC; Samii VF; Weisbrode SE; Young GS
J Am Vet Med Assoc; 2008 Apr; 232(8):1186-92. PubMed ID: 18412532
[TBL] [Abstract][Full Text] [Related]
11. Mammary carcinoma: Comparative oncology between small animals and humans-New therapeutic tools.
Frénel JS; Nguyen F
Reprod Domest Anim; 2023 Sep; 58 Suppl 2():102-108. PubMed ID: 37312625
[TBL] [Abstract][Full Text] [Related]
12. Tumour grading and the one-year post-surgical prognosis in feline mammary carcinomas.
Castagnaro M; Casalone C; Bozzetta E; De Maria R; Biolatti B; Caramelli M
J Comp Pathol; 1998 Oct; 119(3):263-75. PubMed ID: 9807728
[TBL] [Abstract][Full Text] [Related]
13. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
14. Expression of HIF-1α and VEGF in feline mammary gland carcinomas: association with pathological characteristics and clinical outcomes.
Chen B; Lin SJ; Li WT; Chang HW; Pang VF; Chu PY; Lee CC; Nakayama H; Wu CH; Jeng CR
BMC Vet Res; 2020 May; 16(1):125. PubMed ID: 32375802
[TBL] [Abstract][Full Text] [Related]
15. Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 1: Canine Mammary Carcinomas.
Chocteau F; Abadie J; Loussouarn D; Nguyen F
Front Vet Sci; 2019; 6():388. PubMed ID: 31788485
[No Abstract] [Full Text] [Related]
16. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
[TBL] [Abstract][Full Text] [Related]
17. Feline mammary adenocarcinoma: tumor size as a prognostic indicator.
Viste JR; Myers SL; Singh B; Simko E
Can Vet J; 2002 Jan; 43(1):33-7. PubMed ID: 11802667
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
[TBL] [Abstract][Full Text] [Related]
19. Molecular phenotype of primary mammary tumours and distant metastases in female dogs and cats.
Beha G; Muscatello LV; Brunetti B; Asproni P; Millanta F; Poli A; Benazzi C; Sarli G
J Comp Pathol; 2014; 150(2-3):194-7. PubMed ID: 24060151
[TBL] [Abstract][Full Text] [Related]
20. Proposal for a Histological Staging System of Mammary Carcinomas in Dogs and Cats. Part 2: Feline Mammary Carcinomas.
Chocteau F; Boulay MM; Besnard F; Valeau G; Loussouarn D; Nguyen F
Front Vet Sci; 2019; 6():387. PubMed ID: 31788484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
